• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchTalis Biomedical
    Picture of Talis Biomedical logo

    TLIS — Talis Biomedical Share News

    $1.600.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro Cap
    • Market Cap
      $2.92m
    • Enterprise Value
      -$56.95m
    • Revenue
      $2.13m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • TLIS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    TLIS Dividends
    • Brief: Talis Appoints Jeryl Hilleman To Board Of Directors

      18/03/2021 12:37
    • NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:16 PM

      10/03/2021 18:17
    • Talis withdraws COVID-19 test emergency use application, shares drop

      08/03/2021 15:29
    • Brief: Talis Provides Update On Regulatory Pathway For Emergency Use Authorization (EUA) Of Its Talis One Covid-19 Test

      08/03/2021 13:14
    • Talis: COVID-19 test kit maker surges 80% in market debut

      12/02/2021 18:43
    • NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM

      12/02/2021 09:00
    • Brief: Talis Announces Pricing Of IPO

      12/02/2021 04:40
    • Live Markets: Bumble generates buzz as IPO pace set to stumble

      09/02/2021 17:50
    • Brief: Talis Biomedical Corp Sees IPO Of Up To 10 Mln Shares Expected To Be Priced Between $14 And $16 Per Share

      08/02/2021 13:57
    Previous123Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.